Hot High Tech Stocks To Own For 2015

Hot High Tech Stocks To Own For 2015: Varian Medical Systems Inc.(VAR)

Varian Medical Systems, Inc. designs, manufactures, sells, and services equipment and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery, and brachytherapy worldwide. Its Oncology Systems segment offers products, such as linear accelerators, brachytherapy afterloaders, treatment simulation and verification equipment, and accessories; and information management, treatment planning, and image processing software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, doctors? offices, and cancer care clinics. The company?s X-ray Products segment provides x-ray tubes for use in a range of applications, including computed tomography scanning, radiographic or fluoroscopic imaging, mammography, special procedures, and industrial applications; and flat panel digital image detectors for filmless x-ray imaging. It sells t h ese products to imaging systems original equipment manufacturers that incorporate them into their medical diagnostic, dental, veterinary, and industrial imaging systems; independent service companies; and directly to end-users. The company also designs, manufactures, sells, and services Linatron x-ray accelerators, imaging processing software, and image detection products for security and inspection purposes, such as cargo screening at ports and borders, and nondestructive examination in various applications. In addition, it develops products and systems for delivering proton therapy; and technologies in the areas of digital X-ray imaging technology, volumetric and functional imaging, improved X-ray sources, and technology for security and cargo screening applications. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headq! uartered in Palo Alto , California.

Advisors' Opinion:

• [By WWW.GURUFOCUS.COM]

  Varian Medical Systems (VAR) has been a staple in our portfolio since the fall of 2005. The stock has rebounded smartly, up +31% from its April 2013 lows through the first quarter. Varian continues to be the global market share and technological leader in the radiation oncology business. Unfortunately, the incidence of cancer continues its deadly growth. In the U.S. alone, the American Cancer Society projects that some 1.7 million people will be diagnosed with cancer. Expectations of new cancer cases around the world are approaching 25 million over the next three decades. Of these new cases, approximately two-颅thirds will be treated with some sort of radiation therapy. Varian has been at the forefront of linear particle accelerator since the late 1940's. Today the Company's installed base numbers over 7,300 LINACS across the globe a 60% market share. As impressive as that may sound, the availability of state-颅of-颅the-颅art radiation therapy (radiosurger y and proton therapy) outside of the U.S. is woefully low. The developed world has access to 35 to 110 LINACS per million people over the age of 65. In the U.S., it's 110 LINACS per million. Western Europe and Japan is 35 to 65 per million. In India, Africa, Eastern Europe and Southeast Asia there are between 1 and 20 machines per million. In China there is less than 10 machines per million. Complementing the Company's long-颅term growth opportunity in radiation therapy is the secular trend in the "digitization of radiology," which is a key driver of their lucrative software and flat-颅panel services business, plus their X-颅ray tube replacement business that sells into the installed base of competing LINACS. The Company's initiatives to drive greater productivity continue to bear fruit. In 2013 sales per employee increased 14% and operating income per employee increased 20% over 2012 lev! els. Such! productivity has helped the Company offset the continuing losses as t hey rollout their pro

• [By Ben Levisohn]

  Intuitive Surgical has fallen 4.4% to $381.39 today, but doesn’t seem to be having much of an impact on comparable companies. Hologic (HOLX) has ticked up 0.2% to $22.06, Danaher (DHR) has fallen -.4% to $72.05 and Varian Medical Systems (VAR) has gained 0.2% to $78.70.

• [By Ben Levisohn]

  Varian Medical Systems (VAR) and Stryker (SYK) are heading in opposite directions after reporting very different earnings after the close today.

  Getty Images

  Shares of Stryker have gained 0.5% to $79–they were up as much as 3.1% at $81–after reporting a profit of $1.23, beating forecasts for $1.22, while revenue came in at $2.47 billion, ahead of forecasts for $2.43 billion. Stryker also said that its full year earnings would come in between $4.74 and $4.90 using new amortization rules. Because of that change it’s hard to tell how that compares to consensus estimates for $4.57.

  Varian, meanwhile, has dropped 0.6% to $82 after it said it earned 91 cents a share, up 6% from a year ago and ahead of analyst forecasts for 90 cents, according to FactSet. Varian also predicted that full-year earnings would come in between $4.22 and $4.32 a share, straddling the consensus estimate of $4.29.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/hot-high-tech-stocks-to-own-for-2015-2.html